Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
CareFirst Blue Cross Blue Shield July 2017 Medical Policy Updates
CareFirst Blue Cross Blue Shield posts July 2017 Medical Policy Updates:
CareFirst Blue Cross Blue Shield posts July 2017 Medical Policy Updates »
The following Medical Policies have been revised.
July 2017
History of Changes:
NEW POLICY/OPERATING PROCEDURE REVISION: UPDATE 07/17/17:
07/17/17 Rhinomanometry and Acoustic Rhinometry, 2.01.008
Allergy Immunotherapy, 2.01.017
Allergy Testing, 2.01.023
Corneal Cross Linking for Treatment of Keratoconus and Corneal Ectasia,
2.01.064
Implanted Pulmonary Artery Pressure Monitor for Congestive Heart Failure,
2.02.015
Assisted Reproductive Technology (ART) Procedures: In Vitro Fertilization
(IVF) Gamete Intrafallopian Transfer (GIFT) Zygote Intrafallopian Transfer
(ZIFT), 4.02.001
Assisted Reproductive Technology (ART): Artificial Insemination (AI) /
Intrauterine Insemination (IUI), 4.02.009
Human Papillomavirus (HPV) Recombinant Vaccines, 5.01.017
Digital Breast Tomosynthesis, 6.01.044
Obesity and Morbid Obesity , 7.01.036
Treatments for Urinary Incontinence, 7.01.041
Percutaneous Lysis of Epidural Adhesions, 7.01.083
Islet Cell Transplantation, 7.03.007
Clinical Trial Mandates, Maryland and Virginia, 10.01.001
Tumor Markers, 11.01.001
Gene Expression Assays for Managing Prostate Cancer, 11.01.064
NEW POLICY/OPERATING PROCEDURE REVISION: UPDATE 07/17/17:
07/17/17 Rhinomanometry and Acoustic Rhinometry, 2.01.008
Allergy Immunotherapy, 2.01.017
Allergy Testing, 2.01.023
Corneal Cross Linking for Treatment of Keratoconus and Corneal Ectasia,
2.01.064
Implanted Pulmonary Artery Pressure Monitor for Congestive Heart Failure,
2.02.015
Assisted Reproductive Technology (ART) Procedures: In Vitro Fertilization
(IVF) Gamete Intrafallopian Transfer (GIFT) Zygote Intrafallopian Transfer
(ZIFT), 4.02.001
Assisted Reproductive Technology (ART): Artificial Insemination (AI) /
Intrauterine Insemination (IUI), 4.02.009
Human Papillomavirus (HPV) Recombinant Vaccines, 5.01.017
Digital Breast Tomosynthesis, 6.01.044
Obesity and Morbid Obesity , 7.01.036
Treatments for Urinary Incontinence, 7.01.041
Percutaneous Lysis of Epidural Adhesions, 7.01.083
Islet Cell Transplantation, 7.03.007
Clinical Trial Mandates, Maryland and Virginia, 10.01.001
Tumor Markers, 11.01.001
Gene Expression Assays for Managing Prostate Cancer, 11.01.064
CareFirst Blue Cross Blue Shield posts July 2017 Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.